AI-driven clinical trial simulation that models patient responses before trials enroll.
QuantHealth is a Tel Aviv, Israel-based provider of an AI-driven clinical trial simulation platform for pharma and biotech, using predictive modeling to test and optimize trials before patients enroll or capital is committed. Led by CEO Orr Inbar, it has simulated 600+ clinical trials across 30 indications at up to 90% predictive accuracy and partners with 12 of the world's top 20 pharmaceutical companies. In August 2026 it raised a $45M Series B led by Qumra Capital, with Pitango HealthTech, Sanofi Ventures, and Artofin, to accelerate simulation-first clinical development.
Healthcare📍 Tel Aviv, Israel
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is QuantHealth going public?
No. QuantHealth is private and has not filed to go public. There is no S-1 on file.
What is QuantHealth's valuation in 2026?
No confirmed valuation is on record for QuantHealth. The roster shows funding and investors where they are public; it does not estimate a mark.
Has QuantHealth filed an S-1?
No public S-1 is on file for QuantHealth.
Who are QuantHealth's investors?
QuantHealth's investors include Qumra Capital, Pitango HealthTech, Sanofi Ventures, Artofin.
Can you buy QuantHealth stock?
No. QuantHealth is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for QuantHealth on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
CEO
Orr Inbar
HQ
Tel Aviv, Israel
Total Raised
$45M
Growth
Partners with 12 of the top 20 pharma; 600+ trials simulated at up to 90% accuracy
Last Round
Series B — $45M (Aug 2026) · Lead: Qumra Capital
IPO Status
private
Fundraising Status
Series B · $45M · 1 mo ago
privateTotal raised $45M1 disclosed rounds
Funding History
Round
Amount
Date
Lead Investor
Post-Money
Series B
$45M
Aug 2026
Qumra Capital
—
Vertical Intelligence — Biotech / Gene Therapy
No name-verified sponsor record on ClinicalTrials.gov for QuantHealth — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-09-19. Re-checked weekly.
Talent Signal
Hiring trend
▲ Hiring uptrend
+20% vs 2026-08
Open roles
6
via greenhouse
Product-build share
17%
engineering, research, product, design
Trajectory
expanding
go-to-market push — Only 17% of open roles build product — hiring is concentrated in sales/marketing/ops (3 of 6 open roles are other).
No tracked executive churn; open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Senior AI Research EngineerBookkeeper Director of Algorithms DevelopmentDirector of Strategic PartnershipsIT SpecialistOperations Manager
Counted from QuantHealth's live job board as of 2026-09-14; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Founders & Key People
Orr Inbar
Investors
Qumra Capital · Pitango HealthTech · Sanofi Ventures · Artofin
Products
AI clinical trial simulation platform
Simulation-first / in-silico clinical development
Competitors
Unlearn.AI · Formation Bio · Median Technologies · Aignostics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.